Comments
FDA grants priority review to Roche's breast cancer drug
07.11.2012. | (Reuters) - Roche, the world's biggest maker of cancer drugs, said U.S. health regulators granted a priority review to its experimental breast cancer drug TDM-1, expediting the review process for the marketing application of the drug....
